-
Plant Cell Lysis Buffer: From Extract to Insight
2026-08-27
Plant Cell Lysis Buffer for WB and IP can do more than improve protein recovery: it can help preserve the phosphorylation, ubiquitination, and protein-complex information needed for mechanistic assays. This article connects K1126 workflow design with the MAPK10–KRT16 metastasis study while clearly defining cross-domain limitations.
-
Dasatinib Monohydrate in Gastric Assembloids
2026-08-27
Use Dasatinib Monohydrate as a calibrated kinase-pathway probe in patient-derived gastric cancer assembloids, not merely as a single-cell cytotoxicity reagent. This workflow connects imatinib-resistant BCR-ABL inhibition with tumor–stroma drug-response studies while preserving matched epithelial and stromal biology.
-
Computational Saturation Mutagenesis Maps SHP2 Mutations
2026-08-26
This study combines computational saturation mutagenesis, structural energy analysis, functional assays, and clinical variant data to map how more than 9,000 SHP2 substitutions affect autoinhibition. Its central insight is that mutations destabilizing the closed SHP2 conformation can increase phosphatase activity, signaling, proliferation, and disease relevance.
-
Hydrocortisone (B1951): Practical Research Workflow
2026-08-26
Hydrocortisone (SKU B1951) provides a defined glucocorticoid hormone reference for receptor-signaling, inflammation, endothelial barrier, and stress-response assays. It is suitable for controlled research workflows but requires DMSO-based preparation because it is insoluble in water and ethanol; the product should not be treated as a clinical formulation or as evidence for an untested model.
-
Rottlerin as a PKCδ Probe for Better Assay Design
2026-08-25
Rottlerin is a PKC inhibitor whose value extends beyond a single potency measurement. This guide connects PKCδ signaling, time-dependent cellular phenotypes, and transport-aware assay design to improve interpretation in cancer and barrier biology research.
-
L-Threonine: From Nutrient Flux to Translation
2026-08-25
L-Threonine is more than a routine media component: it is a controllable input for studying protein synthesis, nutrient signaling, metabolic flux, and translational phenotypes. This thought-leadership guide connects rigorous L-Threonine workflows with orthogonal alkaline phosphatase measurements while clearly separating nutrient modulation from direct pharmacology.
-
PR-619: Deubiquitylating Enzymes Inhibitor
2026-08-24
PR-619 is a cell-permeable, reversible deubiquitylating enzymes inhibitor with broad activity against cysteine-dependent DUBs. It increases intracellular ubiquitinated proteins without directly inhibiting proteasomal catalytic activity, supporting ubiquitination pathway research, autophagy assays, cancer biology research, and neurodegenerative disease models.
-
Proteoform-Specific Drug Interactions in Native Membranes
2026-08-24
Lutomski and colleagues developed a native mass spectrometry workflow that releases membrane proteins and signaling complexes directly from retinal rod disc membranes, preserving links between proteoforms, lipid modifications, and molecular interactions. The study shows how this approach can distinguish drug interactions with native PDE6 and lipidated G-protein proteoforms, offering a practical framework for studying off-target pharmacology that conventional assays may miss.
-
Sodium Citrate for 3D SERS Arrays
2026-08-23
Sodium citrate offers a practical way to tune ionic strength, pH, and metal–polymer interactions during citrate-conditioned gold nanoparticle assembly. This workflow translates a highly reproducible polymer pen lithography strategy into a controlled optimization plan for sensitive, uniform SERS substrates.
-
WZ4003 Lowers Tau Ser356 in Alzheimer’s Models
2026-08-22
Taylor et al. characterize tau phosphorylated at Ser356 as a pathology-associated species that accumulates with Alzheimer’s disease progression and localizes near synapses. Using mouse and human brain slice cultures, the study shows that pharmacological NUAK inhibition with WZ4003 lowers p-tau Ser356, while also revealing important differences between mouse and human ex vivo responses.
-
DiscoveryProbe Metabolism-related Compound Library Guide
2026-08-22
Build mechanism-first screens around metabolic enzymes, lipid regulators, and cell-based pathway responses with a ready-to-use small-molecule collection. The workflow connects biochemical screening to oxidative-stress and PPAR signaling readouts while emphasizing controls, orthogonal validation, and practical troubleshooting.
-
SC 79 Akt Activator: Workflow & Troubleshooting
2026-08-21
SC 79 is a cytosolic Akt activator for resolving how Akt phosphorylation affects neuronal survival, inflammatory aging, and stress responses. This practical guide combines assay design, washout experiments, pathway controls, and troubleshooting for more interpretable results.
-
Entecavir (BMS200475) for HBV Assays
2026-08-20
Build reproducible HBV replication assays with Entecavir, from DMSO stock preparation through resistance-aware readouts. This guide connects a potent polymerase inhibitor to practical wild-type, lamivudine-resistant, and longitudinal study designs.
-
MLN4924 HCl Salt: NAE Research Workflows
2026-08-20
MLN4924 HCl salt gives researchers a temporally controllable way to interrogate NAE-dependent cullin-RING ligase activity, protein turnover, cell-cycle control, and inflammatory cell death. This workflow connects pathway validation in cancer biology research with a reference-supported strategy for testing how viral proteins exploit host ubiquitination machinery.
-
Valemetostat and Dual EZH1/2 Inhibition in ATL
2026-08-19
The reference paper examines valemetostat, the first approved dual EZH1/2 inhibitor, and explains why simultaneous blockade of both PRC2 catalytic subunits is relevant to adult T-cell leukemia/lymphoma. Its clinical synthesis links the epigenetic mechanism to responses in relapsed or refractory disease while highlighting the need for larger controlled studies.